主動植入式醫療設備市場：依產品、最終用戶和地區分類

Active Implantable Medical Devices Market, By Product, By End Users, By Geography

出版日期: 2026年04月01日 | 出版商:

Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計2026年，主動式植入式醫療設備市場規模將達294.9億美元，2033年將達到492.5億美元。預計從2026年到2033年，該市場將以7.6%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	294.9億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	7.60%	2033年市場規模預測：	492.5億美元

全球主動式植入式醫療設備（IMD）市場的成長主要受全球人口老化和慢性病盛行率上升的驅動。主動式植入式醫療設備是指植入人體用來治療多種疾病的電池供電醫療設備。主要的主動植入式醫療設備包括植入式心臟整流去顫器（ICD）、神經刺激設備和植入式藥物幫浦。 ICD廣泛用於治療危及生命的心臟疾病，例如心搏過速和室顫。神經刺激設備可用於控制慢性疼痛以及治療癲癇和帕金森氏症等神經系統疾病。植入式藥物幫浦有助於將藥物有效輸送局部，用於治療癌症和關節炎等疾病。持續的醫療進步以及對小型化和先進植入式醫療器材研發的日益重視，預計將在預測期內推動主動式植入式醫療設備市場的成長。

市場動態

慢性病高發生率的增加、微創手術需求的成長以及心臟病和神經系統疾病盛行率的上升，都可能推動全球主動植入式醫療設備（ IMD）市場的成長。根據聯合國預測，到2050年，全球整體60歲以上人口將從目前的10億增加到21億。由於植入式醫療器械具有長期療效和易於遠端監測等優勢，人們越來越傾向於選擇植入式醫療器械而非傳統藥物療法和醫療設備，可能會促進主動植入式醫療設備的普及。然而，高成本植入式醫療器材的保險覆蓋範圍有限（尤其是在開發中國家）、因安全問題導致的頻繁產品召回以及嚴格的監管核准，可能會在預測期內阻礙市場成長。機器人技術、生物列印和3D列印技術的持續創新，以及用於長期植入的小型電池供電設備的研發，可能為主動植入式醫療設備市場的參與者帶來成長機會。

本次調查的主要特點

本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數分析了全球主動植入式醫療設備市場的主要參與者：公司亮點、產品系列、主要特徵、財務績效和策略。
透過利用本報告中的見解，企業行銷負責人和經營團隊可以就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
全球主動植入式醫療設備市場報告的目標受群眾外包括該行業的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
透過分析全球主動植入式醫療設備市場所使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第7章競爭情勢

公司簡介
- Medtronic plc
- Abbott Laboratories
- Boston Scientific Corporation
- LivaNova PLC
- Biotronik SE & Co. KG
- Cochlear Ltd.
- William Demant Holding A/S
- Sonova Holding AG
- MED-EL
- Nurotron Biotechnology Co. Ltd.
- Zimmer Biomet Holdings, Inc.
- Nevro Corp.
- Second Sight Medical Products, Inc.
- Nuvectra Corporation
- Aleva Neurotherapeutics SA
- Pixium Vision
- Retina Implant AG
- Corindus Vascular Robotics, Inc.

第8章分析師建議

機會分析
分析師意見
Coherent Opportunity Map

第9章：調查方法

參考
調查方法

簡介目錄

Product Code: CMI1126

Active Implantable Medical Devices Market is estimated to be valued at USD 29.49 Bn in 2026 and is expected to reach USD 49.25 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.6% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 29.49 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	7.60%	2033 Value Projection:	USD 49.25 Bn

Global active implantable medical devices market growth is driven by rising aging population and increasing prevalence of chronic diseases worldwide. Active implantable medical devices are battery powered medical devices that are implanted inside the human body to treat various medical conditions. Some key active implantable medical devices include implantable cardioverter defibrillators (ICDs), neurostimulators, and implantable drug pumps. ICDs are extensively used to treat life threatening cardiac conditions like tachycardia and ventricular fibrillation. Neurostimulators help in managing chronic pain as well as neurological disorders such as epilepsy and Parkinson's disease. Implantable drug pumps assist in effective localized drug delivery for conditions like cancer and arthritis. Ongoing medical advancement and growing focus on development of miniaturized and technologically advanced implantable devices can drive the active implantable medical devices market growth during the forecast period.

Market Dynamics

Rising geriatric population base that is highly susceptible to chronic diseases, increasing demand for minimally invasive procedures, growing prevalence of cardiac disorders and neurological conditions can drive the global active implantable medical devices market growth. According to the United Nations, the population aged 60 years and above is projected to reach 2.1 billion globally by 2050 from 1 billion currently. Growing preference for implantable devices over conventional drug therapy and medical devices due to advantages such as long term effectiveness and easy remote monitoring can boost adoption of active implantable medical devices. However, limited reimbursement coverage for high cost implantable devices especially in developing nations, frequent product recalls owing to safety issues, and stringent regulatory approvals can hamper the market growth during the forecast period. Ongoing technological innovation in the field of robotics, bioprinting, 3D printing and development of miniature battery powered devices for long term implantation can offer growth opportunities for active implantable medical devices market players.

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global active implantable medical devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Medtronic, Cochlear Ltd, Abbott, LivaNova PLC, Boston Scientific Corporation, Myomo, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up gradation, market expansion, and marketing tactics.
Global active implantable medical devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global active implantable medical devices market.

Market Segmentation

Product Insights (Revenue, USD Bn, 2021 - 2033)
Implantable Cardioverter Defibrillators
Implantable Cardiac Pacemakers
Ventricular Assist Devices
Implantable Heart Monitors/Insertable Loop Recorders
Neurostimulators
Implantable Hearing Devices
Others
End Users Insights (Revenue, USD Bn, 2021 - 2033)
Hospitals
Ambulatory Surgery Center
Specialty Clinics
Others
Regional Insights (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
Medtronic plc
Abbott Laboratories
Boston Scientific Corporation
LivaNova PLC
Biotronik SE & Co. KG
Cochlear Ltd.
William Demant Holding A/S
Sonova Holding AG
MED-EL
Nurotron Biotechnology Co. Ltd.
Zimmer Biomet Holdings, Inc.
Nevro Corp.
Second Sight Medical Products, Inc.
Nuvectra Corporation
Aleva Neurotherapeutics SA
Pixium Vision
Retina Implant AG
Corindus Vascular Robotics, Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By End User
- Market Snapshot, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Active Implantable Medical Devices Market, By Product, 2021 - 2033, (USD Bn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Implantable Cardioverter Defibrillators
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Implantable Cardiac Pacemakers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Ventricular Assist Devices
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Implantable Heart Monitors/Insertable Loop Recorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Neurostimulators
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Implantable Hearing Devices
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others (fully-automatic vial-filling machine, etc.)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Active Implantable Medical Devices Market, By End User, 2021 - 2033, (USD Bn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Ambulatory Surgery Center
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Specialty Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Active Implantable Medical Devices Market, By Region, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

7. Competitive Landscape

Company Profiles
- Medtronic plc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Abbott Laboratories
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Boston Scientific Corporation
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- LivaNova PLC
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Biotronik SE & Co. KG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Cochlear Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- William Demant Holding A/S
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Sonova Holding AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- MED-EL
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Nurotron Biotechnology Co. Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Zimmer Biomet Holdings, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Nevro Corp.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Second Sight Medical Products, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Nuvectra Corporation
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Aleva Neurotherapeutics SA
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Pixium Vision
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Retina Implant AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Corindus Vascular Robotics, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies